Introduction Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder associated
with cognitive and behavioral impairments and motor symptoms. Magnetic resonance …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by
the loss of upper and lower motor neurons. Presently, three FDA-approved drugs are …

Neuroimaging biomarkers have shown high potential to map the disease processes in the
application to neurodegenerative diseases (NDD), eg, diffusion tensor imaging (DTI). For …

Abstract Amyotrophic Lateral Sclerosis (ALS) is a rare disease and also known as Lou
Gehrig's disease. In addition, this disease is characterized by a progression in the nerve …

To develop diagnostic imaging approaches, this paper emphasizes the transformational
potential of merging geophysics with health sciences. Diagnostic imaging technology …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease
characterized by motor neuron degeneration. The development of ALS involves metabolite …

Currently, amyotrophic lateral sclerosis (ALS) disease is considered fatal since it affects the
central nervous system with no cure or clear treatments. This disease affects the spinal cord …

Amyotrophic lateral sclerosis (ALS) is the most prevalent type of motor neuron disease
(MND) and is diagnosed with a delay from the first appearance of symptoms. Surrogate …

The goal of this Special Issue is to report new research progress and reviews concerning
amyotrophic lateral sclerosis (ALS). Patients with ALS diagnosis are clinically highly …

The arrival of genotype-specific therapies in amyotrophic lateral sclerosis (ALS) signals the
dawn of precision medicine in motor neuron diseases (MNDs). After decades of academic …